Image by David Clode

Customized Weight Loss

Are you tired of struggling to lose weight?

Tried every "diet" and still can't seem to loose those extra pounds?

Your personal metamorphosis awaits!

Weight Loss Medications

Options Include:

  • Semaglutide

  • Phentermine

  • Bupropion/Naltrexone

  • Sermorelin

  • Lipo-Mino

  • And many others....

Programs are designed for each unique individual to meet your needs and goals. 

Medications often give the extra push & jump start that you need to gain momentum and be successful!

They are an adjunct to healthy eating habits and exercise that can help you transform your body, mind, and life!

Meet Sara!
(Actual Patient)

Starting Weight - 5'2" & 190 pounds - BMI 34.75
3 Month weight loss - 40 pounds!
Current weight 150 pounds- BMI 27.44 

She used weight loss medication, diet, and exercise to achieve amazing results to look and feel better!


What is it?​

  • A prescription medication that acts like human glucagon-like peptide-1 (GLP-1)

  • A subcutaneous injection given once a week in the fat of your abdomen, with or without food

  • Administer on the same day each week at home!



How does it work? 


  • Delays stomach emptying. This leads to a feeling of fullness and satisfaction with smaller meal sizes.

  • Slows intestinal motility.

  • Lowers blood sugar, in part by reducing the production of sugar in the liver.

  • Stimulates insulin secretion by the pancreas.

  • Decreases insulin resistance.



Possible benefits of Semaglutide: 


  • Reduce weight 

  • Lower blood pressure 

  • Kidney protection

  • Cardioprotection

Semaglutide is a GLP-1 agonist and was first approved in the U.S in 2017 as a method to improve glycemic control in patients with Type 2 diabetes. It has been shown to be an effective solution for patients who are having difficulty losing weight. This medication now carries a FDA indication (Wegovy) as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in overweight or obese adult patients. The New England Journal of Medicine's publication of the STEP trial revealed more than 50 percent of trial participants lost 15 percent of their body weight, and between 33 to 40 percent of participants lost 20 percent of their body weight.

GLP-1 is a hormone produced in the small intestine that simulates insulin secretion and inhibits glucagon secretion, thereby lowering blood sugar. Shorter-acting agonists of the GLP-1 receptor

are particularly effective at lowering post-meal glucose spikes, whereas longer-acting GLP-1 agonists have a balanced effect on lowering post-meal glucose levels as well as fasting glucose levels. This GLP-1 agonist has demonstrated beneficial effects on hyperglycemia in addition to decreased appetite and reduced daily caloric intake.


Vitamin B12 has been shown in studies to assist with the tolerance of treatment with GLP-1 agonists. Two of the most common adverse reactions associated with Semaglutide are nausea and hypophagia. These reactions can be significantly reduced when used in conjunction with Vitamin B12.